A homozygous variant disrupting the PIGH start-codon is associated with developmental delay, epilepsy, and microcephaly.
Alistair T PagnamentaYoshiko MurakamiConsuelo AnzilottiHannah TitheradgeAdam J OatesJenny Mortonnull nullTaroh KinoshitaUsha KiniJenny C TaylorPublished in: Human mutation (2018)
Defective glycosylphosphatidylinositol (GPI)-anchor biogenesis can cause a spectrum of predominantly neurological problems. For eight genes critical to this biological process, disease associations are not yet reported. Scanning exomes from 7,833 parent-child trios and 1,792 singletons from the DDD study for biallelic variants in this gene-set uncovered a rare PIGH variant in a boy with epilepsy, microcephaly, and behavioral difficulties. Although only 2/2 reads harbored this c.1A > T transversion, the presence of ∼25 Mb autozygosity at this locus implied homozygosity, which was confirmed using Sanger sequencing. A similarly-affected sister was also homozygous. FACS analysis of PIGH-deficient CHO cells indicated that cDNAs with c.1A > T could not efficiently restore expression of GPI-APs. Truncation of PIGH protein was consistent with the utilization of an in-frame start-site at codon 63. In summary, we describe siblings harboring a homozygous c.1A > T variant resulting in defective GPI-anchor biogenesis and highlight the importance of exploring low-coverage variants within autozygous regions.
Keyphrases
- intellectual disability
- copy number
- zika virus
- mental health
- genome wide
- autism spectrum disorder
- induced apoptosis
- poor prognosis
- genome wide identification
- cell cycle arrest
- healthcare
- binding protein
- high resolution
- signaling pathway
- gene expression
- endoplasmic reticulum stress
- protein protein
- african american
- genome wide analysis
- temporal lobe epilepsy
- subarachnoid hemorrhage
- blood brain barrier
- brain injury